This course addresses the bridging module “Introduction to Principles in Medicine”. It is designed to equip students entering the Digital Health Program with an informatics/digital engineering background with core competencies in comprehending and evaluating health and disease. The course imparts a working knowledge in systems medicine, medical diagnostics and therapeutics, evidence-based medicine and good clinical practice, health behavior, preventive medicine, and taxonomy of diseases. A second teaching block is designed to cover topics in mental health and neuropsychiatric diseases, chronic diseases, infectious disorders, and concepts in alternative medicine. Students will learn to comprehend, assess and apply health and disease-related information in making and communicating decisions in the digital health context.
This course addresses the bridging module “Introduction to Principles in Medicine”. It is designed to equip students entering the Digital Health Program with an informatics/digital engineering background with core competencies in comprehending and evaluating health and disease. The course imparts a working knowledge in systems medicine, medical diagnostics and therapeutics, evidence-based medicine and good clinical practice, health behavior, preventive medicine, and taxonomy of diseases. A second teaching block is designed to cover topics in mental health and neuropsychiatric diseases, chronic diseases, infectious disorders, and concepts in alternative medicine. Students will learn to comprehend, assess and apply health and disease-related information in making and communicating decisions in the digital health context.
Characteristics of Class Meetings/Lectures: Double block on Monday from 13:30pm
Learning Objectives:
Prof. Dr. med. Erwin Böttinger ist Direktor des Digital Health Centers am Hasso-Plattner-Institut und Professor für Digital Health und Personalisierte Medizin an der gemeinsamen Digital Engineering Fakultät des Hasso Plattner Instituts und der Universität Potsdam. Von 2015 bis Juli 2017 hat er als CEO des Berliner Instituts für Gesundheitsforschung/Berlin Institute of Health (BIH) dessen zukunftsweisende Strategie zu 'Personalisierte Medizin - Neuartige Therapien' maßgeblich bestimmt. Als Gründungsdirektor des Charles Bronfman Instituts für Personalisierte Medizin hat Prof. Böttinger davor personalisierte Medizin und Digital Health in den U.S.A. in die klinische Anwendung gebracht. Durch seine langjährigen Forschungs- und Führungstätigkeiten an akademischen Spitzeneinrichtungen der Medizin in U.S.A., wie der Harvard Medical School, dem Nationalen Krebsforschungsinstitut NCI, und zuletzt der Icahn School of Medicine at Mount Sinai, ist der Mediziner und Wissenschaftler für eine globale Perspektive zur Zukunft der Medizin ausgewiesen.